期刊文献+

Luminex液相芯片技术测定氨甲喋呤对映体耐药A549细胞株中磷酸化酪氨酸激酶受体 被引量:3

Expression of phosphorylated tyrosine kinase receptors in methotrexate enantiomers-resistant A549 cell lines by Luminex multiplex analysis
下载PDF
导出
摘要 目的探讨氨甲喋呤(MTX)对映体诱导的耐药A549细胞株中磷酸化酪氨酸激酶受体(RTKs)的表达差异及受体间的相关性。方法用MTX对映体浓度递增结合低剂量持续诱导肺腺癌A549细胞株,用Luminex液相芯片技术检测L-(+)-MTX/A549细胞、D-(-)-MTX/A549细胞和亲本A549细胞3组细胞中7种磷酸化RTKs[磷酸化表皮生长因子受体(p-EGFR)、磷酸化胰岛素样生长因子1受体(p-IGF-1R)、磷酸化肝细胞生长因子受体(p-HGFR)、磷酸化血小板源性生长因子受体(p-PDGFRβ)、磷酸化人类表皮生长因子受体2(p-HER-2)、磷酸化血管内皮生长因子受体2(p-VEGFR2)、磷酸化血管生成素受体(p-Tie-2)]的表达水平,分析它们之间的相关性。结果 D-(-)-MTX/A549组p-EGFR、p-HER-2的平均荧光强度(MFI)分别为26.91±1.81、16.56±1.15;L-(+)-MTX/A549组的MFI分别为54.13±2.75、16.94±1.44;亲本细胞组的MFI分别为54.38±2.88、33.75±2.49。p-EGFR与p-HER-2显著相关(P<0.05),p-HER-2和p-VEGFR、p-HGFR之间显著相关(P<0.05),其他磷酸化RTKs之间相关关系不显著。结论 MTX对映体诱导的耐药A549细胞株中,p-EGFR表达水平存在手性差异。 Objective To study the differential expression of phosphorylated tyrosine kinase receptors(RTKs) and their correlation in MTX enantiomer-resistant cells.Methods A549 cells were exposed to intermittently and progressively increasing concentration of MTX enantiomers.The expressions of 7 phosphorylated RTKs(p-EGFR,p-IGF-1R,p-HGFR,p-PDGFRβ,p-HER-2,p-VEGFR2 and p-Tie-2) in the cells were detected by the Luminex xMAP system simultaneously,and their relationship was analyzed.Results The median fluorescent intensity(MFI) of p-EGFR and p-HER-2 were 26.91±1.81 and 16.56±1.15 in D-(-)-MTX/A549 cells,54.13±2.75 and 16.94±1.44 in L-(+)-MTX/A549 cells,while 54.38±2.88 and 33.75±2.49 in parent cells.Significant correlation was noted between p-EGFR and p-HER-2(P0.05).p-HER-2 was closely correlated with p-VEGFR and p-HGFR(P0.05).The levels of other phosphorylated RTKs didn′t showed significant correlation in the cells of the three groups.Conclusion There was differential expression of p-EGFR in methotrexate enantiomer-resistant A549 cell lines.
出处 《临床检验杂志》 CAS CSCD 北大核心 2011年第8期564-566,共3页 Chinese Journal of Clinical Laboratory Science
关键词 氨甲蝶呤 A549细胞 对映体 酪氨酸激酶受体 液相芯片 methotrexate A549 cell enantiomer receptor tyrosine kinases liquid chip
  • 相关文献

参考文献8

二级参考文献25

  • 1何晓东,沈佐君,王宁玲.临床氨甲蝶呤血药浓度监测及其制剂中对映体成分分析[J].山东医药,2005,45(5):18-20. 被引量:8
  • 2徐珊,朱利群,罗莉,陈琪,徐昌芬.人绒毛膜癌JAR/VP16多药耐药细胞株的建立及相关基因表达检测[J].南京医科大学学报(自然科学版),2006,26(7):485-490. 被引量:8
  • 3陈公琰,杨朝阳,洪璇,王萌,路璐,张长海.人肺腺癌耐药细胞模型的建立及生物学特性的初步鉴定[J].中华医学杂志,2007,87(13):924-926. 被引量:7
  • 4Cesana GC, Romano F, Piacentini G, et al. Low-dose interleukin-2 administered pre-operatively to patients with gastric cancer activates peripheral and peritumoral lymphocytes but does not affect prognosis[J]. Ann Surg Oncol, 2007,14 (4): 1295-1304.
  • 5Snow K,Judd W. Characterisation of adriamycin- and amsacrine-resistant human leukaemic T cell lines[J]. Br J Cancer, 1991,63(1):17-28.
  • 6Perrotton T,Trompier D,Chang XB,et al. (R)- and (S)-verapamil differentially modulate the multidrug resistant protein MRP1[J]. 2007,282(43) :31542-31548.
  • 7Shen S, He Y,Zeng S. Stereoselective regulation of MDR1 expression in Caco-2 cells by cetirizine enantiomers[J]. Chirality, 2007,19(6) : 485-490.
  • 8YOSHIJI H,GOMEZ DE,SHIBUYA M,et al.Expression of VEGF,its receptor and other angiogenic factors in human breast cancer[J].Cancer Res,1999,56(9):2013-2016.
  • 9CRAMER SM,SCHORNAGEL JH,KALGHATGI KK,et al.Occurrence and significance of D-methotrexate as a contaminant of commercial methotrexate[J].Cancer Res,1984,44(5):1843-1846.
  • 10CHUNG JY,SONG Y,WANG Y,et al.Differential expression of vascular endothelial growth factor (VEGF),endocrine gland derived-VEGF,and VEGF receptors in human placentas from normal and preeclamptic pregnancies[J].J Clin Endocrinol Metab,2004,89(5):2484-2490.

共引文献29

同被引文献22

  • 1袁洪,闾宏伟,桑海强,阳国平,黄志军,林玲,邢晓为.液相蛋白质芯片检测血清C反应蛋白方法的建立[J].临床检验杂志,2007,25(1):7-9. 被引量:2
  • 2Yang R, Li WW, Hoang BH, et al. Quantitative correlation between promoter metbylation and messenger RNA levels of reduced folate caiTier[J]. BMC Cancer,2008,8(6) :12-14.
  • 3Schilsky RL. Methotrexate:an effective agent for treating cancer and building careers. The polyglutamate era [ J ]. Stem Cells, 1996,14 ( 1 ) :29-32.
  • 4Trost BM. Asymmetric catalysis: an enabling science [ J ]. Proc Natl Acad Sci USA,2004,101 (15) :5348-5355.
  • 5Herbst RS, Shin DM. Monoclonal antibodies to target epidermal growth factor receptor-positive tumors: a new paradigm for cancer therapy[J]. Cancer,2002, 94(5) :1593-1611.
  • 6Dunbar SA.Applications of Luminex xMAP technology for rapid, high-throughput multiplexed nucleic acid detection[].Clinica Chimica Acta.2006
  • 7Hanahan D,Weinberg RA.Hallmarks of cancer:the next generation[].Cell.2011
  • 8ElshalMF,McCoy JP.Multiplex bead array assays∶performance e-valuation and comparison of sensitivity to ELISA[].Methods.2006
  • 9Navidad JF, Griswold DJ, Gradus MS, et al. Evaluation of Luminex xTAG gastrointestinal pathogen analyte-specific reagents for high- throughput, simultaneous detection of bacteria, viruses, and para- sites of clinical and public health importance [ J ]. J Clin Microbial, 2013,51 (9) :3018-3024.
  • 10Breuer J, Grose C, Norberg P, et al. A proposal for a common no- menclature for viral clades that form the species varicella-zoster virus : summary of VZV Nomenclature Meeting 2008 [ J ]. J Gen Virol, 2010, 91 (4) :821-828.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部